Watch Ticker

Ovid Therapeutics Inc. Common Stock

Go to Ovid Therapeutics Inc. Common Stock Website

$0.50

0.00 (0.75%)

Live

Previous Close

$0.4963

Day Range

$0 - $0

Previous Day Range

$0.48175 - $0.5124

Market Cap

$35.3 million USD

Day Vol.

Previous Day Vol.

608006

Currency

USD

Primary Exchange

Nasdaq

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Ovid Therapeutics, a biopharmaceutical company focused on brain conditions, announced that its President and COO will present at the upcoming TD Cowen conference. The company is advancing a pipeline of novel small molecule candidates for neurological and neuropsychiatric disorders.

Related tickers: OVID.

Read Full Article

Delveinsight - Epilepsy Market Assessment in the 7MM by 2034 — A Detailed Analysis of Growth Prospects Across Different Types | DelveInsight

The epilepsy market is expected to grow due to an increase in disease prevalence and the launch of emerging therapies. The market is segmented into partial epilepsy, chronic focal epilepsy, and drug-resistant epilepsy, with various treatment options and pipeline drugs.

Related tickers: XENE, OVID.

Read Full Article

Trending Tickers

Please sign in to view